Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ADMS - Adamas Pharmaceuticals trading halted for news pending

ADMS - Adamas Pharmaceuticals trading halted for news pending

Adamas Pharmaceuticals Inc.
After a gain of ~6.4% today, the shares of Adamas Pharmaceuticals (ADMS) was halted for trading with news pending.The news underlying the trading halt has not been specified, however, today is the FDA action date for the company’s marketing application for Gocovri (amantadine) to treat OFF episodes in Parkinson's disease patients receiving levodopa-based therapy.In the premarket today, Adamas surged 12% after announcing a settlement to the patent dispute with Zydus Pharmaceuticals over a generic version of GOCOVRI® (amantadine) extended-release capsules.

For further details see:

Adamas Pharmaceuticals trading halted for news pending
Stock Information
Company Name: Adamas Pharmaceuticals Inc.
Stock Symbol: ADMS
Market: NASDAQ
Website: adamaspharma.com
Menu
ADMS ADMS Quote ADMS Short ADMS News ADMS Articles ADMS Message Board
Get ADMS Alerts

News, Short Squeeze, Breakout and More Instantly...